Рус
Latest news
11/13/2019 Ranking of Russian Pharmaceutical Distributors (Q1 — Q3 2019) November 13, 2019
The Russian pharmaceutical market is developing extremely unevenly in both individual market segments and specific product groups this year. Due to significant cash injections into the public sector, the dynamics in this segment is very different from that in the pharmaceutical retail.
10/29/2019 Database Update: Pharmaceutical Drug Production in Russia (September 2019)
Between January and September 2019, Russia manufactured 295 bln RUB worth of pharmaceutical drugs (manufacturers’ prices, VAT included), which is monetary terms (rubles) 22% higher than that in the same period in 2018. This is also the highest dynamics since 2016. The dynamics in physical terms (units) are +4.7%, or +4.2% if calculated in minimum dosage units (MDU). While these dynamics are far from those in 2016, these can still be considered high after the constant negative dynamics during 2017-2018.
9/26/2019 Database Update: Pharmaceutical Drug Production in Russia (August 2019)
Between January and August 2019, Russia produced 255.8 bln RUB worth of pharmaceutical drugs (manufacturers’ prices, VAT included), which is in monetary terms (rubles) 20.2% higher than that of the same period in 2018. In physical terms, the dynamics are +4.5%, with the production volume of 2.83 bln units. If calculated in minimum dosage units (MDU), the dynamics are +3.5%, with the production volume of 47 bln MDUs.
9/24/2019 Database Update: Import of Veterinary Drugs, Feed Supplements, and APIs to Russia (July 2019)
Between January and July 2019, Russia imported 37.7 bln RUB worth of veterinary products (free circulation prices, VAT included), which is in monetary terms (rubles) 0.1% lower than that of the same period in 2018. The negative dynamics are only due to the import of feed supplements dropping by 12.4%. However, the import of feed supplements is the leader in the volume of import in monetary terms with 19.2 bln RUB. The dynamics in physical terms (units) are only negative, -2.4%.
9/23/2019 Database Update: API Import to Russia (July 2019)
Between January and July 2019, Russia imported 69.5 bln RUB worth of APIs (free circulation prices, VAT included), which is in monetary terms (rubles) 26.5% higher than that of the same period in 2018. As earlier, a significant price increase contributed to the high dynamics. In physical terms (tons), the dynamics are +4.5%, with the import volume of 7 thousand tons.
Our competences
RNC Pharma is focused on providing information about development trends of Russian pharmaceutical market infrastructure component. Our experts also provide services on strategic marketing, such as forecasting, business planning, etc.